NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT
Share Embed Flag
Download ePaper

NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT

NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT

instat.gov.al
from instat.gov.al More from this publisher
07.06.2015 Views

Kodi NK CAS RN Emri 151763-64-3 capromab 152923-56-3 daclizumab 152981-31-2 inolimomab 153101-26-9 regavirumab 154361-48-5 arcitumomab 156227-98-4 afelimomab 156586-89-9 edrecolomab 156586-90-2 cedelizumab 156586-92-4 altumomab 158318-63-9 bectumomab 159445-64-4 odulimomab 162774-06-3 nerelimomab 166089-32-3 lintuzumab 167747-19-5 sulesomab 167747-20-8 felvizumab 167816-91-3 faralimomab 169802-84-0 enlimomab pegol 170277-31-3 infliximab 171656-50-1 igovomab 174722-30-6 keliximab 174722-31-7 rituximab 179045-86-4 basiliximab 180288-69-1 trastuzumab 182912-58-9 clenoliximab 188039-54-5 palivizumab 189261-10-7 natalizumab 192391-48-3 tositumomab 195158-85-1 vepalimomab 195189-17-4 minretumomab 196078-29-2 mepolizumab 197099-66-4 rovelizumab 197462-97-8 hemoglobin raffimer 202833-07-6 morolimumab 202833-08-7 atorolimumab 205923-56-4 cetuximab 205923-57-5 epratuzumab 206181-63-7 ibritumomab tiuxetan 211323-03-4 erlizumab 213327-37-8 oregovomab 214559-60-1 bivatuzumab 214745-43-4 efalizumab 216503-57-0 alemtuzumab

Kodi NK CAS RN Emri 216503-58-1 mitumomab 216669-97-5 sibrotuzumab 216974-75-3 bevacizumab 219649-07-7 labetuzumab 219685-50-4 eculizumab 219685-93-5 pexelizumab 219716-33-3 visilizumab 220578-59-6 gemtuzumab 220651-94-5 ruplizumab 235428-87-2 taplitumomab paptox 241473-69-8 reslizumab 242138-07-4 omalizumab 244096-20-6 gavilimomab 250242-54-7 lemalesomab 252662-47-8 toralizumab 263547-71-3 epitumomab 263547-71-3 epitumomab cituxetan 267227-08-7 apolizumab 272780-74-2 metelimumab 285985-06-0 lerdelimumab 288392-69-8 siplizumab 292819-64-8 ecromeximab 299423-37-3 teneliximab 326859-36-3 fontolizumab 331243-22-2 pascolizumab 331731-18-1 adalimumab 336801-86-6 vapaliximab 339086-80-5 tadocizumab 339177-26-3 panitumumab 339186-68-4 matuzumab 339986-90-2 tucotuzumab celmoleukin 347396-82-1 ranibizumab 356547-88-1 belimumab 357613-77-5 galiximab 357613-86-6 lumiliximab 372075-37-1 sontuzumab 375348-49-5 bertilimumab 375823-41-9 tocilizumab 380610-22-0 talizumab 380610-27-5 pertuzumab 395639-53-9 aselizumab 400010-39-1 cantuzumab mertansine

Kodi NK CAS RN Emri<br />

151763-64-3 capromab<br />

152923-56-3 daclizumab<br />

152981-31-2 inolimomab<br />

153101-26-9 regavirumab<br />

154361-48-5 arcitumomab<br />

156227-98-4 afelimomab<br />

156586-89-9 edrecolomab<br />

156586-90-2 cedelizumab<br />

156586-92-4 altumomab<br />

158318-63-9 bectumomab<br />

159445-64-4 odulimomab<br />

162774-06-3 nerelimomab<br />

166089-32-3 lintuzumab<br />

167747-19-5 sulesomab<br />

167747-20-8 felvizumab<br />

167816-91-3 faralimomab<br />

169802-84-0 enlimomab pegol<br />

170277-31-3 infliximab<br />

171656-50-1 igovomab<br />

174722-30-6 keliximab<br />

174722-31-7 rituximab<br />

179045-86-4 basiliximab<br />

180288-69-1 trastuzumab<br />

182912-58-9 clenoliximab<br />

188039-54-5 palivizumab<br />

189261-10-7 natalizumab<br />

192391-48-3 tositumomab<br />

195158-85-1 vepalimomab<br />

195189-17-4 minretumomab<br />

196078-29-2 mepolizumab<br />

197099-66-4 rovelizumab<br />

197462-97-8 hemoglobin raffimer<br />

202833-07-6 morolimumab<br />

202833-08-7 atorolimumab<br />

205923-56-4 cetuximab<br />

205923-57-5 epratuzumab<br />

206181-63-7 ibritumomab tiuxetan<br />

211323-03-4 erlizumab<br />

213327-37-8 oregovomab<br />

214559-60-1 bivatuzumab<br />

214745-43-4 efalizumab<br />

216503-57-0 alemtuzumab

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!